クリニカルエリア - 免疫療法 - 遺伝子改変T細胞

遺伝子改変T細胞

T cells have been found to play a pivotal role in the immune response against cancer. In fact, the adoptive transfer of T cells expressing genetically engineered chimeric antigen receptors (CARs)¹ has shown great promise in clinical studies addressing chronic or acute lymphocytic leukemia²-³. However, the preparation of CAR T cells for clinical application is quite complex and comprises numerous handling steps.

 

References

  1. Chmielewski, M. et al. (2013) Front Immunol. 4: 371
  2. Kalos, M. et al. (2011) Sci. Transl. Med. 3: 95ra73.
  3. Maus, M. V. et al. (2014) Blood 123: 2625–2635.

Workflow


The CliniMACS Prodigy® enables the entire workflow for the manufacture of CAR T cells, from T cell selection through to cell formulation. Read more...

Products


Learn which products are used to manufacture gene-modified T cells automatically.
 Read more...

Lentigen


Lentigen Technology is a leading provider of custom lentiviral vectors.

Read more...

Contact

Miltenyi Biotec K.K.
TEL +81 3 5646 8910
FAX+81 3 5646 8911
macs@miltenyibiotec.jp
お問い合わせ

Product finder

Antibody panel builder

Toolbox

Loading...

Change country

Please select your country to continue